InvestorsHub Logo
Followers 16
Posts 672
Boards Moderated 0
Alias Born 01/06/2017

Re: Dan88 post# 266611

Saturday, 02/22/2020 9:54:27 AM

Saturday, February 22, 2020 9:54:27 AM

Post# of 723909
I find the statement on slide 10 intriguing:

"• As a result of the Crossover Option, almost 90% of patients have
received DCVax-L at some point: ~67% received it at randomization,
and the rest received DCVax-L after documented disease
progression"

We know that 232 out of the 331 (70%) ended up on the treatment arm.. So how did 70% end up in the treatment arm if they were randomized correctly as suggested by bosch here? I think exs suggestion of pure chance is unlikely.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News